Alan J. Main
2011
In 2011, Alan J. Main earned a total compensation of $949.6K as Executive Vice President of Pharmaceutical Research at Lexicon Pharmaceuticals, a 2% increase compared to previous year.
Compensation breakdown
| Bonus | $80,000 |
|---|---|
| Option Awards | $360,334 |
| Salary | $350,000 |
| Stock Awards | $152,650 |
| Other | $6,629 |
| Total | $949,613 |
Main received $360.3K in option awards, accounting for 38% of the total pay in 2011.
Main also received $80K in bonus, $350K in salary, $152.7K in stock awards and $6.6K in other compensation.
Rankings
In 2011, Alan J. Main's compensation ranked 5,832nd out of 10,747 executives tracked by ExecPay. In other words, Main earned more than 45.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,832 out of 10,747 | 46th |
Division Manufacturing | 2,105 out of 3,960 | 47th |
Major group Chemicals And Allied Products | 470 out of 1,038 | 55th |
Industry group Drugs | 300 out of 786 | 62nd |
Industry Pharmaceutical Preparations | 236 out of 571 | 59th |
Source: SEC filing on March 14, 2014.
Main's colleagues
We found four more compensation records of executives who worked with Alan J. Main at Lexicon Pharmaceuticals in 2011.
News
Lexicon Pharmaceuticals CEO Lonnel Coats' 2023 pay slips 1% to $4.1M
March 26, 2024
Lexicon Pharmaceuticals CEO Lonnel Coats' 2021 pay rises 2% to $3.9M
April 8, 2022
Lexicon Pharmaceuticals CEO Lonnel Coats' 2020 pay stays at $3.9M
March 19, 2021
Lexicon Pharmaceuticals CEO Lonnel Coats' 2019 pay jumps 24% to $3.9M
March 13, 2020
Lexicon Pharmaceuticals CEO Lonnel Coats' 2018 pay jumps 41% to $3.1M
March 14, 2019